UMIN ID: C000000147
Registered date:09/09/2005
A Randomized phase II study of docetaxel versus weekly carboplatin and CPT-11 for previously treated Non-Small cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | second line chemotherapy for Non-Small cell lung cancer |
| Date of first enrollment | 1997/07/01 |
| Target sample size | 64 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | carboplatin/irinotecan combination docetaxel |
Outcome(s)
| Primary Outcome | Primary endpoint:Response rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | patient who received docetaxel or irinotecan |
Related Information
| Primary Sponsor | West Japan Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kyoichi Okishio |
| Address | 1180 Nagasone Sakai, JAPAN Japan |
| Telephone | 072-250-4034 |
| Affiliation | National Hospital Organization Kinki-chuo chest medical center Respiratory Medicine |
| scientific contact | |
| Name | Kyoichi Okishio |
| Address | 1180 Nagasone Sakai, JAPAN Japan |
| Telephone | 072-250-4034 |
| Affiliation | National Hospital Organization Kinki-chuo chest medical center Respiratory Medicine |